| Bioactivity | Darenzepine is a muscarinic receptor inhibitor extracted from patent US 20170095465 A1. |
| Target | muscarinic receptor |
| Invitro | Darenzepine is a muscarinic receptor inhibitor which is useful for the treatment of CNS disorders[1]. |
| Name | Darenzepine |
| CAS | 84629-61-8 |
| Formula | C21H21N3O2 |
| Molar Mass | 347.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Eric Elenko, et al. Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation. US 20170095465 A1. |